Ulrika Birgersdotter-Green & Eric Adler 
Case-Based Device Therapy for Heart Failure [PDF ebook] 

Section I – MANAGEMENT of CARDIOGENIC SHOCK.- Assessment of the Shock Patient and Hemodynamic Monitoring.- IABP and Axial Flow Devices.- Extra-Corporal Devices and ECMO.- Section II – CHRONIC DEVICE THERAPY IN THE ADVANCED HEART FAILURE PATIENT.- Patient Selection.- Inpatient Management.- Outpatient Management of LVAD.- Management of LVAD Complications.- Section III – DEVICES for STAGE C Heart Failure.- Long Term Hemodynamic Monitoring.- Remote Monitoring for Cardiac Implantable Electronic Devices Used in Heart Failure.- Section IV – DEVICE BASED ARRHYTHMIA MANAGEMENT.- Indications for the Implantable Cardioverter Defibrillator.- Implant considerations for the Implantable Cardioverter Defibrillator.- Implantable Cardioverter Defibrillator Programming and Troubleshooting.- Use of the Subcutaneous Implantable Cardioverter Defibrillator in Patients with Heart Failure.- How to Identify and Manage Complications from Cardiac Implantable Electronic Devices.- Management of Implantable Cardioverter Defibrillators in Patients with a Left Ventricular Assist Device.- Indications and Use of the Wearable Cardioverter-Defibrillator.- Cardiac Device Management in Palliative Care.- Section V – CARDIAC RESYNCHRONIZATION THERAPY (CRT).- Indications for Cardiac Resynchronization Therapy.- Implant Considerations for Cardiac Resynchronization Therapy.- Cardiac Resynchronization Therapy Programming and Troubleshooting.- His Bundle and Physiologic Pacing for Cardiac Resynchronization Therapy.- Cardiac Resynchronization Therapy in Patients with Left Ventricular Assist Devices.

Ulrika Birgersdotter-Green, MD, is a board-certified cardiologist who specializes in diagnosing and treating heart rhythm disorders. She directs the Pacemaker and ICD (Implantable Cardioverter Defibrillator) Service at UC San Diego Health and leads one of the largest lead extraction programs in the Western United States. Dr. Birgersdotter-Green’s research interests include the mechanisms of arrhythmias, cardiac resynchronization therapy and developing new methods and indications for cardiac device implantation as well as lead extractions. She is actively involved in large clinical trials evaluating biventricular pacing therapy for heart failure management, new cardiac device technology and publishes regularly in electrophysiology journals. She has also co- authored several major consensus documents involving cardiac device guidelines and serves on the editorial review board for several prominent medical journals, including Heart Rhythm and the Journal of the American Journal of Cardiology. She completed fellowships in cardiology and cardiac electrophysiology at UC San Diego School of Medicine. She completed a fellowship in clinical pharmacology, as well as her internal medicine residency at Vanderbilt University Medical Center in Nashville. She earned her medical degree from the Karolinska Institute in Stockholm, Sweden and is a member of the American Heart Association, the American College of Physicians, European Heart Rhythm Association and a fellow of the Heart Rhythm Society.

Dr. Adler went to Medical school at Boston University, where he was awarded a Sarnoff Research Fellowship in Cardiovascular Disease. He completed his Residency in Internal Medicine at the University of Washington and a Fellowship at the Mount Sinai School of Medicine. He is currently a Clinical Professor of medicine at UCSD, where he is the Medical Director of the Cardiac Transplant Program and the heart failure fellowship’s founding director. While at UCSD, he has been awarded both the resident and fellowship teaching awards and the Daniel O’Connor Translational Research Award. He is a former associate editor of the Journal of the American College of Cardiology and currently an associate editor at Circulation Heart Failure. Dr. Adler’s clinical interests are focused on the care of patients with advanced heart failure, mechanical circulatory support, and cardiac transplantation. Over the last 15 years, he has participated in seminal phase 1-4 studies of new heart failure therapies. He has been a pioneer in the use of Palliative Care to treat patients with cardiovascular disease, a topic in which he helped write the American Heart Associate Guidelines. Additionally, his laboratory performs research on the use of stem cells and gene therapy to study and treat cardiomyopathy.